- Therapeutic Cataract & Refractive
- Lens Technology
- Glasses
- Ptosis
- Comprehensive Eye Exams
- AMD
- COVID-19
- DME
- Ocular Surface Disease
- Optic Relief
- Geographic Atrophy
- Cornea
- Conjunctivitis
- LASIK
- Myopia
- Presbyopia
- Allergy
- Nutrition
- Pediatrics
- Retina
- Cataract
- Contact Lenses
- Lid and Lash
- Dry Eye
- Glaucoma
- Refractive Surgery
- Comanagement
- Blepharitis
- OCT
- Patient Care
- Diabetic Eye Disease
- Technology
ASCRS 2023: Analysis in two subgroups of routine cataract surgery
Edward Hu, MD, PhD, discussed his paper on the single surgeon retrospective comparative analysis of 517 eyes of two subgroups of routine cataract surgery at the 2023 ASCRS annual meeting in San Diego.
Video transcript
Editor’s note: Transcript lightly edited for clarity.
Edward Hu, MD, PhD:
Hello, I'm Dr. Edward Hu, cataract specialist with the Wolfe Eye Clinic in Iowa, and I wanted to share with you some results of a paper I presented at the 2023 ASCRS meeting in San Diego. I presented a paper regarding a single surgeon retrospective comparative analysis of 517 eyes in which they were broken down into two subgroups of routine cataract surgery. One group had had prior refractive surgery, either LASIK or PRK versus the second subgroup which had not had prior refractive surgery.
We analyze the outcomes in terms of vision. and understandably, preoperatively, the refractive group had slightly better visual acuities because they had undergone refractive surgery. Postoperatively, interestingly, the refractive group had slightly better visual outcomes than the patients that had not undergone refractive surgery. Our conclusion is that the monofocal IOL, with the aberration-free design of the Bausch + Lomb enVista likely had contributed to these great outcomes in both subgroups.
